BACKGROUND
Brain metastases are a common and serious consequence for patients with renal cell carcinoma. This study aimed to determine if survival has changed since the introduction of current therapies, identify prognostic factors, update the prognostic index (the Renal Graded Prognostic Assessment [GPA]) in the conte...
P. Sperduto, F. Johri, Hany Soliman et al.· The Lancet Oncology· 0 citations
Investigating the prognostic utility of ML-derived MRI biomarkers in metastatic lung cancer patients found they have independent prognostic relevance in lung cancer-associated brain metastases and incorporation into existing clinical risk calculators could improve prognostication and support more personalized treatment...
S. Chadha, D. Sritharan, Darin Dolezal et al.· Neuro-Oncology Advances· 0 citations
Abstract The optimal timing of consolidative radiotherapy after surgical resection of brain metastases remains controversial. Postoperative treatment is often delayed for wound healing concerns. We reviewed our experience with 146 patients who received accelerated stereotactic radiosurgery (SRS) within 1 - 14 days of b...
K. Alok, Yi An, S. Omay et al.· Neuro-Oncology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.